Arkolith/Insider Trading/QLGN/Form 4

Poirier Michael S.

Chairman and CEO, DirectorQualigen Therapeutics, Inc. (QLGN) · full profile →Form 4 · filed Jun 22, 2022
Net Buying
Open-Market Buys
$17K
Open-Market Sells
$0
Net Open-Market Flow
$17K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 22, 2022Buy(P)30K$0.57$17K199K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-22-017505) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML